Latest news
VCYT Maintained by Piper Sandler -- Price Target Lowered to $54. - GuruFocusGuruFocus · Tue, 04 Aug 2026 17:58:01 GMTVCYT Maintained by Morgan Stanley -- Price Target Lowered to $44 - GuruFocusGuruFocus · Tue, 04 Aug 2026 16:41:15 GMTVCYT Maintained by Stephens & Co. -- Price Target Lowered to $55 - GuruFocusGuruFocus · Tue, 04 Aug 2026 15:09:25 GMTVCYT Maintained by Canaccord Genuity -- Price Target Lowered to $50 - GuruFocusGuruFocus · Tue, 04 Aug 2026 02:36:43 GMTVCYT Looks 19.1% Overvalued on GF Value™ as Shares Drop Amid Ins - GuruFocusGuruFocus · Fri, 31 Jul 2026 14:43:39 GMTVCYT Looks 17.7% Overvalued on GF Value™ After Sharp Stock Drop - GuruFocusGuruFocus · Fri, 31 Jul 2026 07:00:00 GMTVeracyte Inc (VCYT) (Q2 2026) Earnings Call Highlights: Record R - GuruFocusGuruFocus · Fri, 31 Jul 2026 06:06:22 GMTVCYT Looks 55.5% Overvalued on GF Value™ - GuruFocusGuruFocus · Thu, 30 Jul 2026 23:25:22 GMT